The original paper: Erfani, R., Carmichael, C., Sofokleous, T., & Wang, Q. (2022). Nanosecond-pulsed DBD plasma treatment on human leukaemia Jurkat cells and monoblastic U937 cells in vitro. Scientific Reports, 12, 6270. Free to read: doi.org/10.1038/s41598-022-10056-8
The Short Version
Quick summary: Researchers took two types of human blood-cancer cells, put them in a lab dish, and exposed them to a special cool, lightning-like gas called cold plasma. After only one to two minutes, almost all of the cancer cells were dead — no drugs, no heat, no surgery. The most surprising finding: simply swapping which wire was positive and which was negative made the treatment work much faster. Important note: this was an experiment in a lab dish, not on patients — so it is a promising discovery, not a treatment you can get today.
🔤 Jargon Translator — Big Words, Simple Meanings
- Plasma (physics kind)
- A gas so energized it starts conducting electricity, like a tiny controlled lightning bolt. Not the same as blood plasma.
- Cold / non-thermal plasma
- Plasma that looks and feels cool — the particles are electrically “hot” but the gas itself stays near room temperature, so it won’t burn you.
- DBD reactor (Dielectric Barrier Discharge)
- The machine that makes the plasma. Two metal plates create sparks across an insulating surface — think of a controlled, spread-out mini lightning flash.
- Nanosecond pulse
- The electricity is delivered in super-fast bursts — one nanosecond is one-billionth of a second. Fast bursts make the plasma more chemically powerful while staying cool.
- Jurkat and U937 cells
- Two standard “practice” human blood-cancer cell lines that scientists around the world use for experiments. They grow in dishes and stand in for real leukaemia.
- In vitro
- Latin for “in glass” — meaning the experiment happened in a lab dish, not in a living body.
- ROS (Reactive Oxygen Species)
- Charged oxygen particles — think of them as tiny “rusting agents.” A little is normal in cells; too much causes fatal damage. Cold plasma floods cells with them.
- Apoptosis
- “Cell suicide” — the cell’s built-in self-destruct program that activates when damage is beyond repair.
- Necrosis
- Cell death from direct injury — like a burst dam rather than a controlled shutdown.
- IC₅₀ (“fifty-percent killing dose”)
- The exposure time or dose needed to kill half the cells. A lower IC₅₀ means a stronger treatment.
- NAC (N-acetyl cysteine)
- A common antioxidant supplement — a “rust protection” chemical that mops up ROS. Scientists use it to test how much of the killing is caused by ROS.
- p53, BAD, BID, caspase-9
- Names of the body’s internal “damage control” and “self-destruct” genes and proteins. Switching them on is a fingerprint of programmed cell death.
The Story: A Cool Kind of Lightning That Attacks Cancer
Imagine a tiny, tame lightning bolt that is cool to the touch but chemically fierce. That’s essentially what scientists can now make with a simple device — and it turns out cancer cells are surprisingly bad at handling it.
Cancer cells live in a constant state of stress. They grow fast, burn fuel quickly, and produce a lot of internal “rust” (oxidative stress). Healthy cells keep a safety margin of antioxidants; cancer cells often run right at the edge. So when researchers add more rust-inducing particles using cold plasma, cancer cells are often the first to collapse. That’s the basic idea behind plasma medicine — a drug-free way of pushing cancer cells past their breaking point.
The machine and the big switch
The device in this study is called a DBD reactor. It has a thin metal rod hovering just above the liquid holding the cells, with a metal strip underneath the dish. Electricity jumps across the gap, turning the air into a thin sheet of glowing plasma right over the cells.
Most earlier machines sent smooth, wavy electricity (like wall power). This team used super-fast nanosecond pulses — like tapping the gas pedal a billion times a second. The fast taps make the plasma produce far more of its cancer-attacking chemicals while barely warming the sample. One earlier study found this trick boosted production of a key attacking particle (the OH radical) by 100–500%.
Then came the clever twist. The scientists realized they could swap the wires — connecting the rod to the power source (they called this setup “ns-DBD+”) or grounding it (“ns-DBD−”). Same machine, same power — but the plasma changed completely:
| Wiring setup | What the plasma looked like | Strength |
|---|---|---|
| ns-DBD+ (rod connected to power) | Bright, crackly, with thin branching streamers — like a miniature storm | Peak current ~4 Amps |
| ns-DBD− (rod grounded) | Dim, smooth, and evenly spread like a soft glow | Peak current ~9 Amps — about 65% more power |
Why? Because negative electrodes spray out free electrons while positive ones soak them up. Which side faces the cells changes how the attacking particles are born and delivered. The “smooth glow” setup (ns-DBD−) turned out to be the stronger healer — and smoother plasmas are also preferred in medicine because every spot gets an equal dose.
What they did
The team grew the two cancer cell lines in standard lab dishes and treated them directly with the plasma, keeping untreated dishes as controls. To make sure heat wasn’t the killer, they watched the dishes with an infrared camera and paused the treatment whenever the liquid neared body temperature. They then ran a series of checks:
- Blue-dye counting: dead cells soak up a blue dye; live cells push it away. Counted at 2 hours and again at 24 hours after treatment.
- Metabolic check (MTT): measures whether surviving cells are still metabolically alive.
- Death-type test (flow cytometry): glowing dyes reveal how cells died — controlled suicide (apoptosis) or burst-and-spill (necrosis).
- Rust levels (ROS): a green fluorescent dye lights up when internal rust rises.
- Chemical detective work: measuring hydrogen peroxide, nitrite, and nitrate building up in the liquid.
- Gene check (PCR): reading the cells’ “damage control” genes 24 hours after treatment, plus testing the caspase-9 self-destruct enzyme.
- The antidote test: pre-treating some cells with the antioxidant NAC to see if rust-protection could save them.
What they found
1. It worked — fast. Short, gentle exposures only trimmed viability slightly (~90–96% alive). But when they turned up the power, the kill rate soared. Within 2 hours:
- Half the cells were dead after roughly 40–60 seconds with the ns-DBD− setup, and 60–80 seconds with ns-DBD+.
- Nearly 100% were dead after about a minute with ns-DBD−, and around two minutes with ns-DBD+.
2. The killing continued after the plasma switched off. At the 24-hour check, even more cells had died — the plasma leaves behind long-lived chemical “time bombs” in the liquid, and some cells take hours to finish their self-destruct sequence.
3. Both blood-cancer types responded. The second cell line (U937) showed the same pattern, so the effect isn’t a one-cell-line fluke.
4. Cells died both ways. Some underwent clean, programmed suicide (apoptosis); others burst open (necrosis). At the longer exposure, suicide was the dominant route — which is generally the “tidier” kind of cell death.
5. The self-destruct machinery was switched on. Genes that guard against damage and trigger suicide — p53, BAD, BID — were turned up (BAD by nearly 7×), and the caspase-9 executioner enzyme was highly active. Inside the cells, rust levels (ROS) were also clearly elevated.
6. The liquid turned into a mild chemical soup. Hydrogen peroxide spiked in the dish at the 1-hour mark (from near zero to roughly 30 micromolar — comparable to strong disinfectant dilutions) and then faded by 24 hours as cells absorbed it. Nitrite and nitrate stayed elevated.
7. The antidote only half-worked. Cells pre-treated with the antioxidant NAC survived much better — but only about half of them. So rust (ROS) is a major weapon, but not the only one. The plasma also kills through routes that don’t involve rust at all — possibly direct membrane damage and the electric field itself.
Results at a glance
| Question | Answer from the study |
|---|---|
| Which wiring was stronger? | The grounded-rod setup (ns-DBD−) — killed cells about twice as fast |
| Time to kill half the cells | ~40–60 seconds (strong setup) vs ~60–80 seconds (weak setup) |
| Time to kill nearly all cells | ~60–90 seconds (strong) vs ~90–120 seconds (weak) |
| Did it keep working later? | Yes — more cells died at 24 hours than at 2 hours |
| How did cells die? | Both suicide (apoptosis) and bursting (necrosis) |
| Was heat responsible? | No — temperature was capped at 35°C, just below body temperature |
| Was rust (ROS) the only killer? | No — the antidote only partially protected cells |
Why Should Anyone Care?
- A drug-free option with dials. Treatment strength can be tuned with time, frequency, voltage — and now we know wiring direction is another dial. That points toward tailoring plasma to each cancer type.
- A design lesson for engineers. The same box produces two very different plasmas depending on which wire goes where. Future medical plasma devices must treat the electronics as part of the medicine.
- A possible helper, not a replacement. Other studies suggest plasma can boost chemotherapy and even re-sensitize drug-resistant cancers — it may end up as a teammate of existing treatments rather than a rival.
- Honest limits. This was a lab-dish experiment. Treating a real patient would require exposing their blood somehow (perhaps through a dialysis-style machine) or treating liquid that is then applied to cells (plasma-activated liquids). Safety on healthy cells, tests on real patient cells, and trials in living bodies all remain to be done.
Quick Questions, Quick Answers
Can I get plasma cancer treatment at a hospital?
No. Plasma medicine is still experimental for cancer. It has shown promise in lab dishes and early trials for skin problems and wound healing, but cancer treatment remains in the research phase.
Is this the same plasma that’s in blood?
No — completely different thing that happens to share a name. Blood plasma is the liquid part of blood. Physics plasma is an energized gas, like a controlled mini lightning.
Would it hurt healthy cells too?
In lab dishes, cancer cells tend to be more sensitive than healthy cells because they live closer to their stress limit. Whether that’s true and safe inside a human body is one of the big questions researchers are still working on.
Why study leukaemia cells in a dish?
Blood cancers are a natural first target because the cancer cells are already floating in liquid — easy to expose to plasma. Cell lines like Jurkat and U937 are the standard “practice opponents” every lab can use to compare results.
The Bottom Line
In a 2022 study published in Scientific Reports, researchers showed that a tabletop device making cool, lightning-like plasma in billionth-of-a-second pulses could wipe out leukaemia cells in a dish within a minute or two — and that flipping one wire made the device roughly twice as fast. The cells died through a mix of self-destruct programming and direct damage, with chemical “rust” (ROS) doing part — but not all — of the work. It’s an encouraging step toward a future where treating cancer might involve tuning a machine’s dials instead of, or alongside, administering drugs. For now, it remains a lab-bench discovery — fascinating, credible, and worth watching.
Sources and Further Reading
- Erfani, R., Carmichael, C., Sofokleous, T., & Wang, Q. (2022). Nanosecond-pulsed DBD plasma treatment on human leukaemia Jurkat cells and monoblastic U937 cells in vitro. Scientific Reports, 12, 6270. https://doi.org/10.1038/s41598-022-10056-8 (Free to read, open access).
- Turrini, E., et al. (2017). Cold atmospheric plasma induces apoptosis and oxidative stress pathway regulation in T-lymphoblastoid leukemia cells. Oxidative Medicine and Cellular Longevity, 2017.
- Barekzi, N., & Laroussi, M. (2012). Dose-dependent killing of leukemia cells by low-temperature plasma. Journal of Physics D: Applied Physics, 45(42), 422002.
- Yan, D., Sherman, J. H., & Keidar, M. (2017). Cold atmospheric plasma, a novel promising anti-cancer treatment modality. Oncotarget, 8(9), 15977.
- Kaushik, N., et al. (2014). Dielectric barrier discharge plasma efficiently delivers an apoptotic response in human monocytic lymphoma. Plasma Processes and Polymers, 11(12), 1175–1187.
- Conway, G. E., et al. (2016). Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells. British Journal of Cancer, 114(4), 435–443.
About this article: This is an independent plain-language summary written by the LearnPapers editorial team to make peer-reviewed science accessible to everyone. The original study is open access under a Creative Commons Attribution 4.0 license and is linked above. All numbers come from the original paper. This content is for education only and is not medical advice — the research described was done in lab dishes, not on patients.